Award recordCONTRACT

GRIFOLS USA LLC

PIID VA25916E0822· VHA· 259-NETWORK CONTRACT OFFICE 19· 6505 · DRUGS AND BIOLOGICALS· FY2016· $44,426 net obligations· UEI D48FNWJCJ5H5· FL

Description

EXPRESS REPORT: 1 PHARMACY ORDERS 436A60077

Base award description: EXPRESS REPORT: 2 PHARMACY ORDERS

First action · last action
2015-10-02 · 2016-02-25
Transactions
3
First transaction's obligation
$21,986
Base + all options value (sum of deltas)
$44,426
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$44,426$0Base award · 2015-10-02 · this action $21,986 · running total $21,986Modification P00001 · 2015-12-03 · this action $11,386 · running total $33,371Modification P00002 · 2016-02-25 · this action $11,054 · running total $44,426
  • Base2015-10-02+$21,986= $21,986
  • Mod P000012015-12-03+$11,386= $33,371
  • Mod P000022016-02-25+$11,054= $44,426
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-10-02+$21,986$21,986EXPRESS REPORT: 2 PHARMACY ORDERS
Mod P00001· FUNDING ONLY ACTION2015-12-03+$11,386$33,371EXPRESS REPORT: 2 PHARMACY ORDERS 436A60034,436A60046
Mod P00002· FUNDING ONLY ACTION2016-02-25+$11,054$44,426EXPRESS REPORT: 1 PHARMACY ORDERS 436A60077

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI D48FNWJCJ5H5)

AwardOffice · PSC / listingNet obligationsFY
36C26026F0037260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$364,000FY2026
36C26026F0019260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$111,000FY2026
36C26026F0015260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$120,000FY2026
36C26025F0153260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$97,176FY2025
36C26025F0037260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C26325F0017NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS$103,293FY2025

Other recipients under 6505 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25916E2677GRIFOLS THERAPEUTICS LLC259-NETWORK CONTRACT OFFICE 19$12,066FY2016
VA25916P2108BAXALTA US INC.259-NETWORK CONTRACT OFFICE 19$6,212FY2016
VA25916P1705MCKESSON CORPORATION259-NETWORK CONTRACT OFFICE 19$11,043FY2016
VA25916E2674CAREMARK RX, L.L.C.259-NETWORK CONTRACT OFFICE 19$17,262FY2016
VA25916P1805BIOLOGICS, INC.259-NETWORK CONTRACT OFFICE 19$10,442FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25916E0822_3600_-NONE-_-NONE- · retrieved 2026-09-26.